SNSS Financial Facts
Research and development: 6.61MGeneral and administrative: 4M
See Full Income Statement
Other accrued liabilities: 1.86M
Total stockholders' equity: 10.06M
See Full Balance Sheet
Sunesis Pharmaceuticals Inc. (SNSS) Earnings
|
Expand Research on SNSS
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +18.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -39.1% | Normal Earnings Time | N/A |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/8/12  |
 |
Q312 | -$0.37 | -$0.13 | -$0.24 | $265K | $4.17M | N/A |  | | Details |
| 11/10/14 |
|
Q314 | -$0.25 | -$0.17 | -$0.08 | $854K | $1.97M | N/A | | | Details |
| 11/12/13 |
|
Q313 | -$0.16 | -$0.20 | +$0.04 | $1.99M | $1.44M | N/A | | | Details |
| 7/27/17 | Q217 | -$0.41 | -$0.59 | +$0.18 | N/A | $1.43M | = | | | Details | |
| 3/6/14 |
|
Q413 | -$0.15 | -$0.20 | +$0.05 | $2M | $1.37M | N/A | | | Details |
| 5/7/14 |
|
Q114 | -$0.26 | -$0.17 | -$0.09 | $2M | $1.32M | N/A | | | Details |
| 8/5/14 |
|
Q214 | -$0.20 | -$0.17 | -$0.03 | $2M | $1.32M | N/A | | | Details |
| 7/29/13 |
Q213 | -$0.18 | -$0.21 | +$0.03 | $1.99M | $1.22M | N/A | | | Details |
